About: Dyne Therapeutics, Inc., a clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States. The company is developing a portfolio of muscle disease therapeutics, including programs in myotonic dystrophy type 1; duchenne muscular dystrophy; facioscapulohumeral dystrophy; and Pompe disease, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. Dyne Therapeutics, Inc. was incorporated in 2017 and is headquartered in Waltham, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Latest price: $17.12 (+0.06%)
DYN NASDAQ Dyne Therapeutics Inc
Dyne Therapeutics Inc share price
DYN price activity
Last Price
$17.120
Change (24hr)
0.01 USD (0.06%)
Volume
3.22M
Volume (4w avg)
-
Open
$17.31
Day Range
$16.77 - $17.59
Previous Close
$17.11
Last Trade
21 Sep, 8:00 pm GMT+0
Delayed
21 Sep, 8:00 pm GMT+0
DYN price performance
Delayed
21 Sep, 8:00 pm GMT+0
DYN Market Signals